QQ客服 官方微博 反馈留言

	Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches
	Huang, Boshi; Li, Cuicui; Chen, Wenmin; Liu, Tao; Yu, Mingyan; Fu, Lu; Sun, Yueyue; Liu, Huiqing; De Clercq, Erik; Pannecouque, Christoph
刊名	European Journal of Medicinal Chemistry: Chimie Therapeutique
	2015
页码	754-765
关键词	Triazolopyrimidines Structure-based drug design Biological activity HIV-1 RT Physicochemical properties Molecular simulations
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4772266
专题	山东大学
作者单位	1.Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Key Lab Chem Biol,Minist Educ, Jinan 250012 2.Shandong Univ, Sch Pharmaceut Sci
推荐引用方式 GB/T 7714	Huang, Boshi,Li, Cuicui,Chen, Wenmin,et al. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches[J]. European Journal of Medicinal Chemistry: Chimie Therapeutique,2015:754-765.
APA	Huang, Boshi.,Li, Cuicui.,Chen, Wenmin.,Liu, Tao.,Yu, Mingyan.,...&Pannecouque, Christoph.(2015).Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches.European Journal of Medicinal Chemistry: Chimie Therapeutique,754-765.
MLA	Huang, Boshi,et al."Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches".European Journal of Medicinal Chemistry: Chimie Therapeutique (2015):754-765.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。